ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent pr⦠read more
Healthcare
Drug ManufacturersāSpecialty & Generic
23 years
USD
Exclusive to Premium users
$95.35
Price-0.68%
-$0.65
$2.068b
Mid
-
Premium
Premium
-
EBITDA Margin-
Net Profit Margin-
Free Cash Flow Margin$747.399m
-
1y CAGR-
3y CAGR-
5y CAGR-$11.031m
-
1y CAGR-
3y CAGR-
5y CAGR-$0.77
-
1y CAGR-
3y CAGR-
5y CAGR$436.757m
$1.343b
Assets$906.244m
Liabilities$320.078m
Debt23.8%
3.4x
Debt to EBITDA$111.368m
-
1y CAGR-
3y CAGR-
5y CAGR